Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT/NF-κB signaling pathway
Article in International Immunopharmacology (August 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (August 2024)
Article in Medical Oncology (April 2024)
Article in International Journal of Pharmaceutics (February 2024)